Latest Reports in Life Science Research Global Library, Far East & Southern Africa

« Back to Activities

Published: 18 Jan 2016

The slowdown in the economy of China, at the same time that Japan is showing growth and India is investing heavily in Life Sciences, is the right time to consider where business effort is placed in the whole Far East region. It also brings into context the importance of the Japanese market, which remains the largest in the region, together with the emerging economies in these markets. Another region of emerging potential is that of Sub-Sahara & South Africa which like the two Far East reports is now brought up to date with the markets for 2015 as the base line.

Since the autumn we have been telling everyone of the Eastern Majors report (ABA 350.3 for China, India & Japan) which has now been fully updated with the new market base line of 2015. Things get even better as the Asia Pacific Rim report for all the other countries in that region (13 in all) is now also available, with 2015 as the market base line. The Contents Lists and Abstracts can be seen on the Latest Reports page of the web site for both the Eastern Majors (ABA 350.3) and the Asia Pacific report (ABA 355.3).

The extremely rapid growth in these countries is now tempered with a more modest development but with Life Sciences a major focus for all with a range of Applications. The differences are emphasised through the focus on different applications in these major markets as shown below in these charts from the reports.

At a time of some slowdown in the Chinese market the total picture of the opportunities in the whole region is of major importance. In each report the investment by government and industry as well as the market dynamics and its implications are assessed for each country in the reports.

Key factors of importance in the Life Science research sector in these countries are:

  • The total funding for Life Sciences in India is greater than either China or Japan, although a major part is for infrastructure development.
  • The Chinese Life Science research market growth has slowed down into single figures, although still the fastest of these three countries.
  • The role of Hong Kong, which is also analysed separately, is changing with a greater focus toward mainland China and the entry route rather than a major force itself.
  • Japan is recovering from its past economic issues and cost reductions and, although It has low growth this is from the highest base level and it is the largest market.

Biotechnology is dominated by BioPharmaceutical research in each country but with varying levels of activity for Agriculture, Veterinary Medicine and other Industrial (White) Biotechnology applications that show the wider application of Biotechnology in the region as a whole.

The Economic and Political aspects that impact the funding for Life Science research are examined in detail with the base line for market and product quantification based on the events and budgets announced for 2015/16. This gives 2015 as the base line for market quantification so that projections for 2020 are valid and can be used to develop effective plans for the immediate future and into 2017. Link to Contents List & Abstract...

The comments on the Far East apply at a different level to the Sub-Sahara and South Africa region (ABA 365). Here the dominant market is that of South Africa but, like China, its economy has hit major problems with significant losses against other currencies whilst emerging countries such as Nigeria, Kenya, Tanzania and Uganda markets with growing opportunities. The fully updated report provides details of the 2015 markets and their quantification with projections to 2020. Link to Contents List & Abstract...